Adicet Bio
ACET· Manufacturing· Fiscal year ends in December
CEO pay in FY2023Stock -78.9% in FY2023
Chen Schor is the CEO of Adicet Bio and was paid $6.0M in FY2023 (Dec), up 50%.
Pay$100 in the stock at the end of FY21 → $11
Executives3
See all- 1Chen SchorPresident and Chief Executive OfficerFY2023
- 2Blake Aftab, Ph.D.Chief Scientific Officer and Senior Vice PresidentNot disclosed
- 3Julia Maltzman, M.D.Chief Medical OfficerNot disclosed
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allAdicet Bio paid its 3 named executives $10.2M in total in FY2023 (Dec). CEO Chen Schor was paid $6.0M of that.
| Name | ||
|---|---|---|
| Chen SchorPresident and Chief Executive Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Adicet Bio. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 29, 2026 | FY2025 |
| Annual report | 10-K | Mar 12, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 29, 2025 | FY2024 |
| Annual report | 10-K | Mar 6, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 23, 2024 | FY2023 |
| Annual report | 10-K | Mar 19, 2024 | FY2023 |